Pharmaceutical Stocks Positioned as Defensive Play Amid Currency Volatility Says Market Veteran Ambareesh Baliga Whitehawk Therapeutics WHWK Declines 804 Amid Market Weakness 20260515 Genuine GPC Drops 399 Key Support at 8864 20260515 Trump Administration Unveils 17bn Compensation Fund Drops Tax Lawsuit BioHarvest BHST Slips 247 Testing 393 Support 20260515 Affiliated MGRD Q1 2026 Earnings Surprise EPS 823 Up Significant Evaxion EVAX Gains 434 Support Holds at 389 20260518 Pathfinder PBHC Q4 2025 Earnings Revenue NA Matching Views Suspected Ebola Deaths of Red Cross Volunteers in DR Congo Could Impact Regional Stability and Economic Activity Bitcoin Bounces Above 77K as Iran Deal Optimism and Nasdaq Crypto Options Plan Boost Sentiment eHealth EHTH May See Increased Target as Operational Improvements Gain Traction Beyond Inc Acquires Buy Buy Baby Brand Rights Reuniting Iconic Retail Names Kevin Warsh Faces Internal Fed Debate Over Interest Rate Cuts Amid Rising Inflation and Yields TrumpConnected Stock Trades Draw Scrutiny Over Potential Conflicts CXDO Q1 2026 Earnings EPS Surprises 256 Above Estimates EVI Q1 2026 Earnings Significant EPS Miss Drags Stock Lower INMD Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Runway Growth Finance Corp RWAY Q1 2026 Earnings EPS Misses Estimates as Stock Holds Steady EVgo Q1 2026 Earnings Narrower Loss Beats Expectations Amid Steady Operational Progress Prenetics Global PRE Dips 174 as Stock Hovers Near Key Support Zone Gyre Therapeutics GYRE Falters Testing Key Support After 194 Decline CDT Equity Inc CDT Falls Sharply Key Support Levels in Focus After 139 Decline Jazz Pharmaceuticals JAZZ Shares Dip 132 as Stock Tests Key Support Levels Jim Cramer Endorses TJX Companies Business Model Amid Retail Sector Challenges Kestrel Group Ltd Q3 2024 Earnings Reported Loss of 016 Per Share as Stock Edges Higher Okta Q1 2026 Earnings EPS Beat Drives Positive Market Reaction PLAYSTUDIOS Inc MYPS Q1 2026 Earnings EPS Miss Signals Headwinds for Mobile Gaming Developer TAOP Q2 2011 Earnings EPS Misses Estimates Despite Positive Stock Movement CNTB Q1 2026 Earnings Deeper Than Expected Losses as Biotech Continues PreRevenue Phase CANF Q4 2023 Earnings EPS Surges Past Estimates as Clinical Progress Continues Beyond Air Inc XAIR Q1 2026 Earnings Narrowing Losses but Revenue Remains Absent REAX Q1 2026 Earnings Narrowing Losses with Strong Earnings Beat